Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non-Small Cell Lung Cancer × quemliclustat × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Non-Small Cell Lung Cancer 1

Interventions

Docetaxel 5 Carboplatin 3 lorlatinib 2 Vinorelbine 2 Pemetrexed 2 Gemcitabine 2 Cetuximab 2 zimberelimab 1 surufatinib 1 sintilimab 1 quemliclustat 1 pemigatinib 1 pembrolizumab 1 nimotuzumab 1 fludarabine 1 cemiplimab 1 WW Domain-Containing Oxidoreductase 1 S 1 (combination) 1 Paclitaxel 1 Interleukin-2 1 Gene Expression Profiling 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Capecitabine 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05676931 2025-10-02

EDGE-Lung

Gilead Sciences

Phase 2 Active not recruiting

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡